March of Dimes is a nonprofit organization that works to improve the health of mothers and babies. It also committed to ending preventable maternal health risks and deaths, ending preventable preterm birth and infant death, and closing the health equity gap for all families.
Senior Director - Portfolio Strategy and Investment
5 past transactions
Millie
Series A in 2025
Millie is a maternity care platform and clinic that aims to improve clinical outcomes and provide a seamless experience for expectant and new parents, built by mothers and providers with firsthand experience, offering a new type of maternity clinic that supports remote health monitoring, home postpartum visits, and parenthood guidance through an app, including one-to-one doula coaching, and combining clinical care with practical support during and after the maternal phase to simplify access to care and enhance the overall experience for families.
Seven Starling
Series A in 2024
Seven Starling is a digital clinic focused on perinatal and women's behavioral health. It delivers care across fertility, pregnancy, loss, and early motherhood through a platform that combines individualized therapy, peer support, and medication when appropriate. The evidence-based approach targets conditions such as postpartum depression and anxiety and supports patients through pregnancy and early parenting. Research indicates that about 90% of patients feel better within three months.
Raydiant Oximetry
Series A in 2024
Raydiant Oximetry is a medical device company developing a non-invasive fetal monitoring device that measures fetal oxygen levels to improve outcomes for mothers and babies during childbirth and to reduce unnecessary cesarean sections. Founded in 2015 and based in California, the company aims to provide low-cost, real-time monitoring of fetal oxygenation during labor, enabling clinicians to assess fetal well-being and minimize intervention.
Iron Health
Seed Round in 2023
Iron Health specializes in women's healthcare, offering primary care, behavioral health services, mental health support, and weight management programs. They utilize a virtual platform for tailored care pathways and remote consultations.
Katana Pharmaceuticals
Grant in 2020
Katana Pharmaceuticals is a biotech company developing novel treatments for neonatal patient populations and rare pediatric disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.